Skip to main navigation Skip to search Skip to main content

Autoantikörperdiagnostik bei der Wegenerschen Granulomatose.

Translated title of the contribution: Autoantibody diagnosis in Wegener's granulomatosis

G. Lüdemann*, J. Ludemann, B. Nölle, W. L. Gross

*Corresponding author for this work

Abstract

Anticytoplasmic antibodies (ACPA) against myelomonocytic cells were demonstrable in 54 of 72 patients with Wegener's granulomatosis (WG). Other autoantibodies (including ANA, AMAb, RF and anti-ENA) were only found in a low frequence and titre. The presence of ACPA correlated with the severity and activity of the disease. These results demonstrated that ACPA is a valuable tool to establish the diagnosis and to monitor disease activity in WG.

Translated title of the contributionAutoantibody diagnosis in Wegener's granulomatosis
Original languageGerman
JournalImmunitat und Infektion
Volume15
Issue number2
Pages (from-to)74-76
Number of pages3
ISSN0340-1162
Publication statusPublished - 04.1987

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Fingerprint

Dive into the research topics of 'Autoantibody diagnosis in Wegener's granulomatosis'. Together they form a unique fingerprint.

Cite this